Sentinel lymph node biopsy in oral cancer: Validation of technique and clinical implications of added oblique planar lymphoscintigraphy and/or tomography

Acta Radiologica

Volumn 46, Issue 6, 2005, Pages 569-575

  Thomsen, J B ^a   Sorensen J A ^b   Grupe, P ^b   Krogdahl, A ^b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b NONE

Author keywords

Follow up; Histology; Lymphoscintigraphy; Oral cancer; Sentinel lymph node; Tomography

Indexed keywords

COMPUTERIZED TOMOGRAPHY; HISTOLOGY; PATIENT MONITORING; TUMORS;

FOLLOW-UP; LYMPHOSCINTIGRAPHY; ORAL CANCER; SENTINEL LYMPH NODE;

BIOPSY;

COLORING AGENT; DIAGNOSTIC AGENT; KERATIN; RADIOPHARMACEUTICAL AGENT; RHENIUM; TECHNETIUM DERIVATIVE; TECHNETIUM TC 99M RHENIUM COLLOID;

ADULT; AGED; ARTICLE; CANCER STAGING; FEMALE; FOLLOW UP; HUMAN; INTERVENTIONAL RADIOLOGY; LYMPH NODE; LYMPH NODE METASTASIS; MALE; METASTASIS; MIDDLE AGED; MOUTH TUMOR; OBSERVER VARIATION; PATHOLOGY; REPRODUCIBILITY; SCINTISCANNING; SENTINEL LYMPH NODE BIOPSY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SQUAMOUS CELL CARCINOMA; TUMOR RECURRENCE; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COLORING AGENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KERATINS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OBSERVER VARIATION; RADIOLOGY, INTERVENTIONAL; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RHENIUM; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM COMPOUNDS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33644687192     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1080/02841850510021571     Document Type: Article

References (22)

1. Barrera JE, Miller ME, Said S, Jafek BW, Campana JP, Shroyer KR. Detection of occult cervical micrometastases in patients with head and neck squamous cell cancer. Laryngoscope 2003;113:892-6.
2. Cabanas RM. Application of the sentinel node concept in urogenital cancer. Recent Results Cancer Res 2000;157:141-9.
3. Clarke D, Newcombe RG, Mansel RE. The learning curve in sentinel node biopsy: the ALMANAC experience. Ann Surg Oncol 2004;11Suppl 3: 211S-15S.
4. Dunne AA, Kulkens C, Ramaswamy A, Folz BJ, Brandt D, Lippert BM, et al. Value of sentinel lymphonodectomy in head and neck cancer patients without evidence of lymphogenic metastatic disease. Auris Nasus Larynx 2001;28:339-44.
5. Even-Sapir E, Lerman H, Lievshitz G, Khafif A, Fliss DM, Schwartz A, et al. Lymphoscintigraphy for sentinel node mapping using a hybrid SPECT/CT system. J Nucl Med 2003;44:1413-20.
6. Jansen L, Nieweg OE, Kapteijn AE, Valdes Olmos RA, Muller SH, et al. Reliability of lymphoscintigraphy in indicating the number of sentinel nodes in melanoma patients. Ann Surg Oncol 2000;7:624-30.
7. Kapteijn BA, Nieweg OE, Valdes Olmos RA, Liem IH, Panday RK, et al. Reproducibility of lymphoscintigraphy for lymphatic mapping in cutaneous melanoma. J Nucl Med 1996;37:972-5.
8. Kovacs AF, Acker P, Berner U, Risse JH. [Sentinel lymph node excision. Treatment method of the NO neck in patients with oral and oropharyngeal carcinoma]. HNO 2001;49:646-53.
9. Lorberboym M, Minski I, Macadziob S, Nikolov G, Schachter P. Incremental diagnostic value of preoperative 99mTc-MIBI SPECT in patients with a parathyroid adenoma. J Nucl Med 2003;44:904-8.
10. Morton DL, Wen DR, Foshag LJ, Essner R, Cochran A. Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early-stage melanomas of the head and neck. J Clin Oncol 1993; 11:1751-6.
11. Pastore A, Turetta GD, Tarabini A, Turetta D, Feggi L, Pelucchi S. Sentinel lymph node analysis in squamous carcinoma of the oral cavity and oropharynx. Tumori 2002;88:S58-60.
12. Robbins KT, Medina JE, Wolfe GT, Levine PA, Sessions RB, Pruet CW. Standardizing neck dissection terminology. Official report of the Academy's Committee for Head and Neck Surgery and Oncology. Arch Otolaryngol Head Neck Surg 1991;117:601-5.
13. Ross GL, Shoaib T, Scott J, Soutar DS, Gray HW, MacKie R. The learning curve for sentinel node biopsy in malignant melanoma. Br J Plast Surg 2002;55:298-301.
14. Ross G, Shoaib T, Soutar DS, Camilleri IG, Gray HW, Bessent RG, et al. The use of sentinel node biopsy to upstage the clinically NO neck in head and neck cancer. Arch Otolaryngol Head Neck Surg 2002; 128: 1287-91.
15. Shoaib T, Soutar DS, MacDonald DG, Camilleri IG, Dunaway DJ, Gray HW, et al. The accuracy of head and neck carcinoma sentinel lymph node biopsy in the clinically NO neck. Cancer 2001;91:2077-83.
16. Stoeckli SJ, Steinert H, Pfaltz M, Schmid S. Is there a role for positron emission tomography with 18F-fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinoma. Head Neck 2002;24:345-9.
17. Stuckensen T, Kovacs AF, Adams S, Baum RP. Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRI. J Craniomaxillofac Surg 2000;28:319-24.
18. Tafra L. The learning curve and sentinel node biopsy. Am J Surg 2001;182:347-50.
19. Thomsen JB, Sorensen JA, Krogdahl A. Sentinel lymph nodes in cancer of the oral cavity-isolated tumour cells. J Oral Pathol Med 2005;34:65-9.
20. Werner JA, Dunne AA, Folz BJ, Moll R, Behr T. Value of sentinel lymphadenectomy in head and neck cancer. Ann Surg Oncol 2004; 11:267S-70S.
21. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997;349:1864-7.
22. de Wilt JH, Thompson JF, Uren RF, Ka VS, Scolyer RA, McCarthy WH, et al. Correlation between preoperative lymphoscintigraphy and metastatic nodal disease sites in 362 patients with cutaneous melanomas of the head and neck. Ann Surg 2004;239:544-52.